1. Home
  2. INVE vs HOWL Comparison

INVE vs HOWL Comparison

Compare INVE & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • HOWL
  • Stock Information
  • Founded
  • INVE 1990
  • HOWL 2017
  • Country
  • INVE United States
  • HOWL United States
  • Employees
  • INVE N/A
  • HOWL N/A
  • Industry
  • INVE Computer peripheral equipment
  • HOWL Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • HOWL Health Care
  • Exchange
  • INVE Nasdaq
  • HOWL Nasdaq
  • Market Cap
  • INVE 86.5M
  • HOWL 87.4M
  • IPO Year
  • INVE 1997
  • HOWL 2021
  • Fundamental
  • Price
  • INVE $3.48
  • HOWL $1.36
  • Analyst Decision
  • INVE Strong Buy
  • HOWL Strong Buy
  • Analyst Count
  • INVE 2
  • HOWL 2
  • Target Price
  • INVE $7.25
  • HOWL $9.50
  • AVG Volume (30 Days)
  • INVE 38.4K
  • HOWL 263.3K
  • Earning Date
  • INVE 03-11-2025
  • HOWL 03-06-2025
  • Dividend Yield
  • INVE N/A
  • HOWL N/A
  • EPS Growth
  • INVE N/A
  • HOWL N/A
  • EPS
  • INVE 3.10
  • HOWL N/A
  • Revenue
  • INVE $104,217,000.00
  • HOWL $3,386,000.00
  • Revenue This Year
  • INVE N/A
  • HOWL N/A
  • Revenue Next Year
  • INVE N/A
  • HOWL $34.17
  • P/E Ratio
  • INVE $1.15
  • HOWL N/A
  • Revenue Growth
  • INVE 70.57
  • HOWL N/A
  • 52 Week Low
  • INVE $2.95
  • HOWL $1.26
  • 52 Week High
  • INVE $9.24
  • HOWL $8.19
  • Technical
  • Relative Strength Index (RSI)
  • INVE 43.25
  • HOWL 41.40
  • Support Level
  • INVE $3.50
  • HOWL $1.26
  • Resistance Level
  • INVE $3.82
  • HOWL $1.45
  • Average True Range (ATR)
  • INVE 0.18
  • HOWL 0.09
  • MACD
  • INVE -0.01
  • HOWL 0.02
  • Stochastic Oscillator
  • INVE 21.82
  • HOWL 45.45

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: